Cargando…
Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11
Pathogenic variants in SCN1A result in a spectrum of phenotypes ranging from mild febrile seizures to Dravet syndrome, a severe infant-onset epileptic encephalopathy. Individuals with Dravet syndrome have developmental delays, elevated risk for sudden unexpected death in epilepsy (SUDEP), and have m...
Autores principales: | Kearney, Jennifer A., Copeland-Hardin, Letonia D., Duarte, Samantha, Zachwieja, Nicole A., Eckart-Frank, Isaiah K., Hawkins, Nicole A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616761/ https://www.ncbi.nlm.nih.gov/pubmed/35606653 http://dx.doi.org/10.1007/s00335-022-09955-y |
Ejemplares similares
-
Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq
por: Hawkins, Nicole A., et al.
Publicado: (2016) -
Gabra2 is a genetic modifier of Dravet syndrome in mice
por: Hawkins, Nicole A., et al.
Publicado: (2021) -
Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2017) -
The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model
por: Hawkins, Nicole A., et al.
Publicado: (2017) -
Soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice
por: Hawkins, Nicole A., et al.
Publicado: (2021)